Clinical Trial Update: Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the effects of a direct-acting antiviral in chronic hepatitis C patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Assiut University | Conditions: Chronic Hepatitis c | Phase 3 | Status: UNKNOWN